Skip to main content
Erschienen in: Archives of Dermatological Research 4/2018

13.02.2018 | Original Paper

Treatment preferences and treatment satisfaction among psoriasis patients: a systematic review

verfasst von: Aleksandra G. Florek, Catherine J. Wang, April W. Armstrong

Erschienen in: Archives of Dermatological Research | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

A critical gap exists in determining treatment preferences and treatment satisfaction from patient perspectives, which is paramount to achieving therapeutic success. The objective of this systematic review is to determine factors influencing treatment preferences and treatment satisfaction among psoriasis patients. PubMed, EMBASE, and Web of Science databases were searched between November 1, 2010, and December 1, 2017. Observational and interventional research studies published in the English language that discussed patient preferences and patient satisfaction in the treatment of psoriasis were reviewed and synthesized. We utilized data on treatment preferences and treatment satisfaction from 35,388 psoriasis patients based on 60 articles from the years 2010 to 2017. Treatment preferences were heterogeneous and changed over time among psoriasis patients. Across all treatment modalities, the most important treatment attributes were treatment location, probability of improvement, and delivery method. For biologics specifically, the most important attributes were risk of adverse events and probability of treatment benefit. Factors that influenced patients’ preferences for certain treatments included age, sex, comorbidities, disease duration, and prior treatments. Notably, some psoriasis patients placed higher importance on a treatment’s process attributes (e.g., access and delivery) over its outcome attributes (e.g., efficacy). Overall, patient satisfaction with existing therapies remains modest; however, those treated with biologic agents exhibited highest treatment satisfaction over oral therapy, phototherapy, and topical therapy.
Literatur
1.
Zurück zum Zitat Alcusky M, Lee S, Lau G, Chiu GR, Hadker N, Deshpande A, Fleming S, Vance N, Fakharzadeh S (2017) Dermatologist and patient preferences in choosing treatments for moderate to severe psoriasis. Dermatol Ther (Heidelb) 7(4):463–483CrossRef Alcusky M, Lee S, Lau G, Chiu GR, Hadker N, Deshpande A, Fleming S, Vance N, Fakharzadeh S (2017) Dermatologist and patient preferences in choosing treatments for moderate to severe psoriasis. Dermatol Ther (Heidelb) 7(4):463–483CrossRef
2.
Zurück zum Zitat Armstrong AW, Robertson AD, Wu J, Schupp C, Lebwohl MG (2013) Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the national psoriasis foundation surveys, 2003–2011. JAMA Dermatol 149(10):1180–1185CrossRefPubMed Armstrong AW, Robertson AD, Wu J, Schupp C, Lebwohl MG (2013) Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the national psoriasis foundation surveys, 2003–2011. JAMA Dermatol 149(10):1180–1185CrossRefPubMed
4.
Zurück zum Zitat Augustin M, Blome C, Costanzo A, Dauden E, Ferrandiz C, Girolomoni G, Gniadecki R, Iversen L, Menter A, Michaelis-Wittern K, Morita A, Nakagawa H, Reich K (2014) Nail assessment in psoriasis and psoriatic arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes. Br J Dermatol 170(3):591–598CrossRefPubMed Augustin M, Blome C, Costanzo A, Dauden E, Ferrandiz C, Girolomoni G, Gniadecki R, Iversen L, Menter A, Michaelis-Wittern K, Morita A, Nakagawa H, Reich K (2014) Nail assessment in psoriasis and psoriatic arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes. Br J Dermatol 170(3):591–598CrossRefPubMed
5.
Zurück zum Zitat Blome C, Costanzo A, Dauden E, Ferrandiz C, Girolomoni G, Gniadecki R, Iversen L, Menter A, Michaelis-Wittern K, Morita A, Nakagawa H, Reich K, Augustin M (2016) Patient-relevant needs and treatment goals in nail psoriasis. Qual Life Res 25(5):1179–1188CrossRefPubMed Blome C, Costanzo A, Dauden E, Ferrandiz C, Girolomoni G, Gniadecki R, Iversen L, Menter A, Michaelis-Wittern K, Morita A, Nakagawa H, Reich K, Augustin M (2016) Patient-relevant needs and treatment goals in nail psoriasis. Qual Life Res 25(5):1179–1188CrossRefPubMed
6.
Zurück zum Zitat Blome C, Gosau R, Radtke MA, Reich K, Rustenbach SJ, Spehr C, Thaci D, Augustin M (2016) Patient-relevant treatment goals in psoriasis. Arch Dermatol Res 308(2):69–78CrossRefPubMed Blome C, Gosau R, Radtke MA, Reich K, Rustenbach SJ, Spehr C, Thaci D, Augustin M (2016) Patient-relevant treatment goals in psoriasis. Arch Dermatol Res 308(2):69–78CrossRefPubMed
7.
Zurück zum Zitat Callis Duffin K, Yeung H, Takeshita J, Krueger GG, Robertson AD, Troxel AB, Shin DB, Van Voorhees AS, Gelfand JM (2014) Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practice. Br J Dermatol 170(3):672–680CrossRefPubMed Callis Duffin K, Yeung H, Takeshita J, Krueger GG, Robertson AD, Troxel AB, Shin DB, Van Voorhees AS, Gelfand JM (2014) Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practice. Br J Dermatol 170(3):672–680CrossRefPubMed
8.
Zurück zum Zitat Cazzaniga S, Lo Scocco G, Schincaglia E, Mercuri SR, Chimenti S, Saraceno R, Naldi L (2014) Double-blind, within-patient, randomized, clinical trial comparing fluorine-synthetic fiber socks with standard cotton socks in improving plantar psoriasis. J Dermatolog Treat 25(1):26–29CrossRefPubMed Cazzaniga S, Lo Scocco G, Schincaglia E, Mercuri SR, Chimenti S, Saraceno R, Naldi L (2014) Double-blind, within-patient, randomized, clinical trial comparing fluorine-synthetic fiber socks with standard cotton socks in improving plantar psoriasis. J Dermatolog Treat 25(1):26–29CrossRefPubMed
9.
Zurück zum Zitat Christophers E, Segaert S, Milligan G, Molta CT, Boggs R (2013) Clinical improvement and satisfaction with biologic therapy in patients with severe plaque psoriasis: results of a European cross-sectional observational study. J Dermatolog Treat 24(3):193–198CrossRefPubMed Christophers E, Segaert S, Milligan G, Molta CT, Boggs R (2013) Clinical improvement and satisfaction with biologic therapy in patients with severe plaque psoriasis: results of a European cross-sectional observational study. J Dermatolog Treat 24(3):193–198CrossRefPubMed
10.
Zurück zum Zitat Courtenay M, Carey N, Stenner K, Lawton S, Peters J (2011) Patients’ views of nurse prescribing: effects on care, concordance and medicine taking. Br J Dermatol 164(2):396–401CrossRefPubMed Courtenay M, Carey N, Stenner K, Lawton S, Peters J (2011) Patients’ views of nurse prescribing: effects on care, concordance and medicine taking. Br J Dermatol 164(2):396–401CrossRefPubMed
11.
Zurück zum Zitat Driessen RJB, Bisschops LA, Adang EMM, Evers AW, van de Kerkhof PCM, de Jong E (2010) The economic impact of high-need psoriasis in daily clinical practice before and after the introduction of biologics. Br J Dermatol 162(6):1324–1329CrossRefPubMed Driessen RJB, Bisschops LA, Adang EMM, Evers AW, van de Kerkhof PCM, de Jong E (2010) The economic impact of high-need psoriasis in daily clinical practice before and after the introduction of biologics. Br J Dermatol 162(6):1324–1329CrossRefPubMed
12.
Zurück zum Zitat Eastman WJ, Malahias S, Delconte J, DiBenedetti D (2014) Assessing attributes of topical vehicles for the treatment of acne, atopic dermatitis, and plaque psoriasis. Cutis 94(1):46–53PubMed Eastman WJ, Malahias S, Delconte J, DiBenedetti D (2014) Assessing attributes of topical vehicles for the treatment of acne, atopic dermatitis, and plaque psoriasis. Cutis 94(1):46–53PubMed
13.
14.
Zurück zum Zitat Feldman SR, Horn EJ, Balkrishnan R, Basra MK, Finlay AY, McCoy D, Menter A, van de Kerkhof PC (2008) Psoriasis: improving adherence to topical therapy. J Am Acad Dermatol 59(6):1009–1016CrossRefPubMed Feldman SR, Horn EJ, Balkrishnan R, Basra MK, Finlay AY, McCoy D, Menter A, van de Kerkhof PC (2008) Psoriasis: improving adherence to topical therapy. J Am Acad Dermatol 59(6):1009–1016CrossRefPubMed
15.
Zurück zum Zitat Ferwerda M, Van Beugen S, Van Burik A, Van Middendorp H, De Jong EMGJ., Van De Kerkhof PCM, Van Riel PLCM., Evers AWM (2013) What patients think about E-health: patients’ perspective on internet-based cognitive behavioral treatment for patients with rheumatoid arthritis and psoriasis. Clin Rheumatol 32(6):869–873CrossRefPubMed Ferwerda M, Van Beugen S, Van Burik A, Van Middendorp H, De Jong EMGJ., Van De Kerkhof PCM, Van Riel PLCM., Evers AWM (2013) What patients think about E-health: patients’ perspective on internet-based cognitive behavioral treatment for patients with rheumatoid arthritis and psoriasis. Clin Rheumatol 32(6):869–873CrossRefPubMed
16.
Zurück zum Zitat Feuerhahn J, Blome C, Radtke M, Augustin M (2012) Validation of the patient benefit index for the assessment of patient-relevant benefit in the treatment of psoriasis. Arch Dermatol Res 304(6):433–441CrossRefPubMed Feuerhahn J, Blome C, Radtke M, Augustin M (2012) Validation of the patient benefit index for the assessment of patient-relevant benefit in the treatment of psoriasis. Arch Dermatol Res 304(6):433–441CrossRefPubMed
17.
Zurück zum Zitat Finch T, Shim TN, Roberts L, Johnson O (2015) Treatment satisfaction among patients with moderate-to-severe psoriasis. J Clin Aesthet Dermatol 8(4):26–30PubMedPubMedCentral Finch T, Shim TN, Roberts L, Johnson O (2015) Treatment satisfaction among patients with moderate-to-severe psoriasis. J Clin Aesthet Dermatol 8(4):26–30PubMedPubMedCentral
18.
Zurück zum Zitat Franzke N, Montenbruck M, Langenbruch AK, Beikert FC, Kresken J, Augustin M (2013) Drug supply for psoriasis—results from a national pharmacy network. J Dtsch Dermatol Ges 11(7):638–643PubMed Franzke N, Montenbruck M, Langenbruch AK, Beikert FC, Kresken J, Augustin M (2013) Drug supply for psoriasis—results from a national pharmacy network. J Dtsch Dermatol Ges 11(7):638–643PubMed
19.
Zurück zum Zitat Fruhauf J, Schwantzer G, Ambros-Rudolph CM, Weger W, Ahlgrimm-Siess V, Salmhofer W, Hofmann- Wellenhof R (2012) Pilot study on the acceptance of mobile teledermatology for the home monitoring of high-need patients with psoriasis. Australas J Dermatol 53(1):41–46CrossRefPubMed Fruhauf J, Schwantzer G, Ambros-Rudolph CM, Weger W, Ahlgrimm-Siess V, Salmhofer W, Hofmann- Wellenhof R (2012) Pilot study on the acceptance of mobile teledermatology for the home monitoring of high-need patients with psoriasis. Australas J Dermatol 53(1):41–46CrossRefPubMed
20.
Zurück zum Zitat Gisondi P, Farina S, Giordano MV, Zanoni M, Girolomoni G (2012) Attitude to treatment of patients with psoriasis attending SPA center. G Ital Dermatol Venereol 147(5):483–489PubMed Gisondi P, Farina S, Giordano MV, Zanoni M, Girolomoni G (2012) Attitude to treatment of patients with psoriasis attending SPA center. G Ital Dermatol Venereol 147(5):483–489PubMed
21.
Zurück zum Zitat Gottlieb A, Korman NJ, Gordon KB, Feldman SR, Lebwohl M, Koo JY, Van Voorhees AS, Elmets CA, Leonardi CL, Beutner KR, Bhushan R, Menter A (2008) Guidelines of care for the management of psoriasis and psoriatic arthritis: Sect. 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol 58(5):851–864CrossRefPubMed Gottlieb A, Korman NJ, Gordon KB, Feldman SR, Lebwohl M, Koo JY, Van Voorhees AS, Elmets CA, Leonardi CL, Beutner KR, Bhushan R, Menter A (2008) Guidelines of care for the management of psoriasis and psoriatic arthritis: Sect. 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol 58(5):851–864CrossRefPubMed
22.
Zurück zum Zitat Hashimoto T, Kawakami T, Tsuruta D, Hamada T, Natsuaki Y, Fukuda S, Koga H, Sogame R, Ohyama B, Ono F, Karashima T, Nakama T, Dainichi T, Ishii N, Yasumoto S (2012) Low-dose cyclosporin improves the health-related quality of life in Japanese psoriasis patients dissatisfied with topical corticosteroid monotherapy. Australas J Dermatol 53(3):202–206CrossRefPubMed Hashimoto T, Kawakami T, Tsuruta D, Hamada T, Natsuaki Y, Fukuda S, Koga H, Sogame R, Ohyama B, Ono F, Karashima T, Nakama T, Dainichi T, Ishii N, Yasumoto S (2012) Low-dose cyclosporin improves the health-related quality of life in Japanese psoriasis patients dissatisfied with topical corticosteroid monotherapy. Australas J Dermatol 53(3):202–206CrossRefPubMed
23.
Zurück zum Zitat Hauber AB, Gonzalez JM, Schenkel B, Lofland JH, Martin S (2011) The value to patients of reducing lesion severity in plaque psoriasis. J Dermatolog Treat 22(5):266–275CrossRefPubMed Hauber AB, Gonzalez JM, Schenkel B, Lofland JH, Martin S (2011) The value to patients of reducing lesion severity in plaque psoriasis. J Dermatolog Treat 22(5):266–275CrossRefPubMed
24.
Zurück zum Zitat Hjortsberg C, Bergman A, Bjarnason A, Heikkila H, Hjelmgren J, Svensson A, Tennvall GR (2011) Are treatment satisfaction, quality of life, and self-assessed disease severity relevant parameters for patient registries? Experiences from Finnish and Swedish patients with psoriasis. Acta Derm Venereol 91(4):409–414CrossRefPubMed Hjortsberg C, Bergman A, Bjarnason A, Heikkila H, Hjelmgren J, Svensson A, Tennvall GR (2011) Are treatment satisfaction, quality of life, and self-assessed disease severity relevant parameters for patient registries? Experiences from Finnish and Swedish patients with psoriasis. Acta Derm Venereol 91(4):409–414CrossRefPubMed
25.
Zurück zum Zitat Hong CH, Papp KA, Lophaven KW, Skallerup P, Philipp S (2017) Patients with psoriasis have different preferences for topical therapy, highlighting the importance of individualized treatment approaches: randomized phase IIIb PSO-INSIGHTFUL study. J Eur Acad Dermatol Venereol 31(11):1876–1883CrossRefPubMedPubMedCentral Hong CH, Papp KA, Lophaven KW, Skallerup P, Philipp S (2017) Patients with psoriasis have different preferences for topical therapy, highlighting the importance of individualized treatment approaches: randomized phase IIIb PSO-INSIGHTFUL study. J Eur Acad Dermatol Venereol 31(11):1876–1883CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Ito K, Imafuku S, Nakayama J (2013) Therapeutic preferences are different in psoriatic and atopic dermatitis patients: a questionnaire-based study. J Dermatol 40(4):292–294CrossRefPubMed Ito K, Imafuku S, Nakayama J (2013) Therapeutic preferences are different in psoriatic and atopic dermatitis patients: a questionnaire-based study. J Dermatol 40(4):292–294CrossRefPubMed
27.
Zurück zum Zitat Iversen L, Jakobsen HB (2016) Patient preferences for topical psoriasis treatments are diverse and difficult to predict. Dermatol Ther (Heidelb) 6(2):273–285CrossRef Iversen L, Jakobsen HB (2016) Patient preferences for topical psoriasis treatments are diverse and difficult to predict. Dermatol Ther (Heidelb) 6(2):273–285CrossRef
28.
Zurück zum Zitat Jong MC, Ermuth U, Augustin M (2013) Plant-based ointments versus usual care in the management of chronic skin diseases: a comparative analysis on outcome and safety. Compliment Ther Med 21(5):453–459CrossRef Jong MC, Ermuth U, Augustin M (2013) Plant-based ointments versus usual care in the management of chronic skin diseases: a comparative analysis on outcome and safety. Compliment Ther Med 21(5):453–459CrossRef
29.
Zurück zum Zitat Korman NJ, Zhao Y, Lu J, Tran MH (2015) Psoriasis disease severity affects patient satisfaction with treatment. Dermatol Online J 21(7):1–10 Korman NJ, Zhao Y, Lu J, Tran MH (2015) Psoriasis disease severity affects patient satisfaction with treatment. Dermatol Online J 21(7):1–10
30.
Zurück zum Zitat Krenzer S, Radtke M, Schmitt-Rau K, Augustin M (2011) Characterization of patient-reported outcomes in moderate to severe psoriasis. Dermatology 223(1):80–86CrossRefPubMed Krenzer S, Radtke M, Schmitt-Rau K, Augustin M (2011) Characterization of patient-reported outcomes in moderate to severe psoriasis. Dermatology 223(1):80–86CrossRefPubMed
31.
Zurück zum Zitat Kromer C, Peitsch WK, Herr R, Schmieder A, Sonntag D, Schaarschmidt ML (2017) Treatment preferences for biologicals in psoriasis: experienced patients appreciate sustainability. J Dtsch Dermatol Ges 15(2):189–200 Kromer C, Peitsch WK, Herr R, Schmieder A, Sonntag D, Schaarschmidt ML (2017) Treatment preferences for biologicals in psoriasis: experienced patients appreciate sustainability. J Dtsch Dermatol Ges 15(2):189–200
32.
Zurück zum Zitat Kromer C, Schaarschmidt ML, Schmieder A, Herr R, Goerdt S, Peitsch WK (2015) Patient preferences for treatment of psoriasis with biologicals: a discrete choice experiment. PLoS One 10(6):e0129120CrossRefPubMedPubMedCentral Kromer C, Schaarschmidt ML, Schmieder A, Herr R, Goerdt S, Peitsch WK (2015) Patient preferences for treatment of psoriasis with biologicals: a discrete choice experiment. PLoS One 10(6):e0129120CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Lambert J, Hol CW, Vink J (2014) Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: 4- and 12-week interim results from the PRO-long study. J Eur Acad Dermatol Venereol 28(12):1723–1731CrossRefPubMed Lambert J, Hol CW, Vink J (2014) Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: 4- and 12-week interim results from the PRO-long study. J Eur Acad Dermatol Venereol 28(12):1723–1731CrossRefPubMed
34.
Zurück zum Zitat Lambert J, Hol CW, Vink J (2015) Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: final analysis of the 52-week PRO-long study. J Eur Acad Dermatol Venereol 29(12):2349–2355CrossRefPubMedPubMedCentral Lambert J, Hol CW, Vink J (2015) Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: final analysis of the 52-week PRO-long study. J Eur Acad Dermatol Venereol 29(12):2349–2355CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Lecluse LL, Tutein Nolthenius JL, Bos JD, Spuls PI (2009) Patient preferences and satisfaction with systemic therapies for psoriasis: an area to be explored. Br J Dermatol 160(6):1340–1343CrossRefPubMed Lecluse LL, Tutein Nolthenius JL, Bos JD, Spuls PI (2009) Patient preferences and satisfaction with systemic therapies for psoriasis: an area to be explored. Br J Dermatol 160(6):1340–1343CrossRefPubMed
36.
Zurück zum Zitat MacKenzie H, Thavaneswaran A, Chandran V, Gladman DD (2011) Patient-reported outcome in psoriatic arthritis: a comparison of Web-based versus paper-completed questionnaires. J Rheumatol 38(12):2619–2624CrossRefPubMed MacKenzie H, Thavaneswaran A, Chandran V, Gladman DD (2011) Patient-reported outcome in psoriatic arthritis: a comparison of Web-based versus paper-completed questionnaires. J Rheumatol 38(12):2619–2624CrossRefPubMed
37.
Zurück zum Zitat Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, Lebwohl M, Koo JY, Elmets CA, Korman NJ, Beutner KR, Bhushan R (2008) Guidelines of care for the management of psoriasis and psoriatic arthritis: Sect. 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 58(5):826–850CrossRefPubMed Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, Lebwohl M, Koo JY, Elmets CA, Korman NJ, Beutner KR, Bhushan R (2008) Guidelines of care for the management of psoriasis and psoriatic arthritis: Sect. 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 58(5):826–850CrossRefPubMed
38.
Zurück zum Zitat Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb A, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R (2009) Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol 60(4):643–659CrossRefPubMed Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb A, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R (2009) Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol 60(4):643–659CrossRefPubMed
39.
Zurück zum Zitat Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb A, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R (2010) Guidelines of care for the management of psoriasis and psoriatic arthritis: Sect. 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. J Am Acad Dermatol 62(1):114–135CrossRefPubMed Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb A, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R (2010) Guidelines of care for the management of psoriasis and psoriatic arthritis: Sect. 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. J Am Acad Dermatol 62(1):114–135CrossRefPubMed
40.
Zurück zum Zitat Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb AB, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R (2009) Guidelines of care for the management of psoriasis and psoriatic arthritis: Sect. 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol 61(3):451–485CrossRefPubMed Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb AB, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R (2009) Guidelines of care for the management of psoriasis and psoriatic arthritis: Sect. 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol 61(3):451–485CrossRefPubMed
41.
Zurück zum Zitat Naldi L, Yawalkar N, Kaszuba A, Ortonne JP, Morelli P, Rovati S, Mautone G (2011) Efficacy and safety of the Betamethasone valerate 0.1% plaster in mild-to-moderate chronic plaque psoriasis: a randomized, parallel-group, active-controlled, phase III study. Am J Clin Dermatol 12(3):191–201CrossRefPubMed Naldi L, Yawalkar N, Kaszuba A, Ortonne JP, Morelli P, Rovati S, Mautone G (2011) Efficacy and safety of the Betamethasone valerate 0.1% plaster in mild-to-moderate chronic plaque psoriasis: a randomized, parallel-group, active-controlled, phase III study. Am J Clin Dermatol 12(3):191–201CrossRefPubMed
42.
Zurück zum Zitat Paul C, Stalder JF, Thaci D, Vincendon P, Brault Y, Kielar D, Tebbs V (2012) Patient satisfaction with injection devices: a randomized controlled study comparing two different etanercept delivery systems in moderate to severe psoriasis. J Eur Acad Dermatol Venereol 26(4):448–455CrossRefPubMed Paul C, Stalder JF, Thaci D, Vincendon P, Brault Y, Kielar D, Tebbs V (2012) Patient satisfaction with injection devices: a randomized controlled study comparing two different etanercept delivery systems in moderate to severe psoriasis. J Eur Acad Dermatol Venereol 26(4):448–455CrossRefPubMed
43.
Zurück zum Zitat Poulin Y, Papp KA, Wasel NR, Andrew R, Fraquelli E, Bernstein G, Chan D (2010) A Canadian online survey to evaluate awareness and treatment satisfaction in individuals with moderate to severe plaque psoriasis. Int J Dermatol 49(12):1368–1375CrossRefPubMed Poulin Y, Papp KA, Wasel NR, Andrew R, Fraquelli E, Bernstein G, Chan D (2010) A Canadian online survey to evaluate awareness and treatment satisfaction in individuals with moderate to severe plaque psoriasis. Int J Dermatol 49(12):1368–1375CrossRefPubMed
44.
Zurück zum Zitat Poulin Y, Wasel N, Chan D, Bernstein G, Andrew R, Fraquelli E, Papp K (2012) Evaluating practice patterns for managing moderate to severe plaque psoriasis: role of the family physician. Can Fam Physician 58(7):e390–e400PubMedPubMedCentral Poulin Y, Wasel N, Chan D, Bernstein G, Andrew R, Fraquelli E, Papp K (2012) Evaluating practice patterns for managing moderate to severe plaque psoriasis: role of the family physician. Can Fam Physician 58(7):e390–e400PubMedPubMedCentral
45.
Zurück zum Zitat Rachakonda TD, Schupp CW, Armstrong AW (2014) Psoriasis prevalence among adults in the United States. J Am Acad Dermatol 70(3):512–516CrossRefPubMed Rachakonda TD, Schupp CW, Armstrong AW (2014) Psoriasis prevalence among adults in the United States. J Am Acad Dermatol 70(3):512–516CrossRefPubMed
46.
Zurück zum Zitat Radtke MA, Langenbruch A, Jacobi A, Schaarschmidt ML, Augustin M (2016) Patient benefits in the treatment of psoriasis: long-term outcomes in German routine care 2007–2014. J Eur Acad Dermatol Venereol 30(10):1829–1833CrossRefPubMed Radtke MA, Langenbruch A, Jacobi A, Schaarschmidt ML, Augustin M (2016) Patient benefits in the treatment of psoriasis: long-term outcomes in German routine care 2007–2014. J Eur Acad Dermatol Venereol 30(10):1829–1833CrossRefPubMed
47.
Zurück zum Zitat Radtke MA, Schaefer I, Blome C, Augustin M (2013) Patient benefit index (PBI) in the treatment of psoriasis—results of the national care study “PsoHealth”. Eur J Dermatol 23(2):212–217PubMed Radtke MA, Schaefer I, Blome C, Augustin M (2013) Patient benefit index (PBI) in the treatment of psoriasis—results of the national care study “PsoHealth”. Eur J Dermatol 23(2):212–217PubMed
48.
Zurück zum Zitat Radtke MA, Spehr C, Reich K, Rustenbach SJ, Feuerhahn J, Augustin M (2016) Treatment satisfaction in psoriasis: development and use of the PsoSat patient questionnaire in a cross-sectional study. Dermatology 232(3):334–343CrossRefPubMed Radtke MA, Spehr C, Reich K, Rustenbach SJ, Feuerhahn J, Augustin M (2016) Treatment satisfaction in psoriasis: development and use of the PsoSat patient questionnaire in a cross-sectional study. Dermatology 232(3):334–343CrossRefPubMed
49.
Zurück zum Zitat Ragnarson Tennvall G, Hjortsberg C, Bjarnason A, Gniadecki R, Heikkila H, Jemec GB, Kragballe K, Miller IM, Svensson A (2013) Treatment patterns, treatment satisfaction, severity of disease problems, and quality of life in patients with psoriasis in three Nordic countries. Acta Derm Venereol 93(4):442–445CrossRefPubMed Ragnarson Tennvall G, Hjortsberg C, Bjarnason A, Gniadecki R, Heikkila H, Jemec GB, Kragballe K, Miller IM, Svensson A (2013) Treatment patterns, treatment satisfaction, severity of disease problems, and quality of life in patients with psoriasis in three Nordic countries. Acta Derm Venereol 93(4):442–445CrossRefPubMed
50.
Zurück zum Zitat Reich K, Zschocke I, Bachelez H, de Jong EM, Gisondi P, Puig L, Warren RB, Mrowietz U (2015) Efficacy of a fixed combination of calcipotriol/betamethasone dipropionate topical gel in adult patients with mild to moderate psoriasis: blinded interim analysis of a phase IV, multicenter, randomized, controlled, prospective study. J Eur Acad Dermatol Venereol 29(6):1156–1163CrossRefPubMed Reich K, Zschocke I, Bachelez H, de Jong EM, Gisondi P, Puig L, Warren RB, Mrowietz U (2015) Efficacy of a fixed combination of calcipotriol/betamethasone dipropionate topical gel in adult patients with mild to moderate psoriasis: blinded interim analysis of a phase IV, multicenter, randomized, controlled, prospective study. J Eur Acad Dermatol Venereol 29(6):1156–1163CrossRefPubMed
51.
Zurück zum Zitat Renzi C, Di Pietro C, Tabolli S (2011) Participation, satisfaction and knowledge level of patients with cutaneous psoriasis or psoriatic arthritis. Clin Exp Dermatol 36(8):885–888CrossRefPubMed Renzi C, Di Pietro C, Tabolli S (2011) Participation, satisfaction and knowledge level of patients with cutaneous psoriasis or psoriatic arthritis. Clin Exp Dermatol 36(8):885–888CrossRefPubMed
52.
Zurück zum Zitat Sandoval LF, Huang KE, Harrison J, Clark A, Feldman SR (2014) Calcipotriene 0.005%-betamethasone dipropionate 0.064% ointment versus topical suspension in the treatment of plaque psoriasis: a randomized pilot study of patient preference. Cutis 94(6):304–309PubMed Sandoval LF, Huang KE, Harrison J, Clark A, Feldman SR (2014) Calcipotriene 0.005%-betamethasone dipropionate 0.064% ointment versus topical suspension in the treatment of plaque psoriasis: a randomized pilot study of patient preference. Cutis 94(6):304–309PubMed
53.
Zurück zum Zitat Schaarschmidt ML, Kromer C, Herr R, Schmieder A, Goerdt S, Peitsch WK (2015) Treatment satisfaction of patients with psoriasis. Acta Derm Venereol 95(5):572–578CrossRefPubMed Schaarschmidt ML, Kromer C, Herr R, Schmieder A, Goerdt S, Peitsch WK (2015) Treatment satisfaction of patients with psoriasis. Acta Derm Venereol 95(5):572–578CrossRefPubMed
54.
Zurück zum Zitat Schaarschmidt ML, Kromer C, Herr R, Schmieder A, Sonntag D, Goerdt S, Peitsch WK (2015) Patient preferences for biologicals in psoriasis: top priority of safety for cardiovascular patients. PLoS One 10(12):e0144335CrossRefPubMedPubMedCentral Schaarschmidt ML, Kromer C, Herr R, Schmieder A, Sonntag D, Goerdt S, Peitsch WK (2015) Patient preferences for biologicals in psoriasis: top priority of safety for cardiovascular patients. PLoS One 10(12):e0144335CrossRefPubMedPubMedCentral
55.
Zurück zum Zitat Schaarschmidt ML, Herr R, Gutknecht M, Wroblewska K, Gerdes S, Sticherling M, Augustin M, Peitsch WK (2017) Patients’ and physicians’ preferences for systemic psoriasis treatments: a nationwide comparative discrete choice experiment (PsoCompare). Acta Derm Venereol. https://doi.org/10.2340/00015555-2834 PubMed Schaarschmidt ML, Herr R, Gutknecht M, Wroblewska K, Gerdes S, Sticherling M, Augustin M, Peitsch WK (2017) Patients’ and physicians’ preferences for systemic psoriasis treatments: a nationwide comparative discrete choice experiment (PsoCompare). Acta Derm Venereol. https://​doi.​org/​10.​2340/​00015555-2834 PubMed
56.
Zurück zum Zitat Schaarschmidt ML, Schmieder A, Umar N, Terris D, Goebeler M, Goerdt S, Peitsch WK (2011) Patient preferences for psoriasis treatments: process characteristics can outweigh outcome attributes. Arch Dermatol 147(11):1285–1294CrossRefPubMed Schaarschmidt ML, Schmieder A, Umar N, Terris D, Goebeler M, Goerdt S, Peitsch WK (2011) Patient preferences for psoriasis treatments: process characteristics can outweigh outcome attributes. Arch Dermatol 147(11):1285–1294CrossRefPubMed
57.
Zurück zum Zitat Schaarschmidt ML, Umar N, Schmieder A, Terris DD, Goebeler M, Goerdt S, Peitsch WK (2013) Patient preferences for psoriasis treatments: impact of treatment experience. J Eur Acad Dermatol Venereol 27(2):187–198CrossRefPubMed Schaarschmidt ML, Umar N, Schmieder A, Terris DD, Goebeler M, Goerdt S, Peitsch WK (2013) Patient preferences for psoriasis treatments: impact of treatment experience. J Eur Acad Dermatol Venereol 27(2):187–198CrossRefPubMed
58.
Zurück zum Zitat Schafer I, Hacker J, Rustenbach SJ, Radtke M, Franzke N, Augustin M (2010) Concordance of the psoriasis area and severity index (PASI) and patient-reported outcomes in psoriasis treatment. Euro J Dermatol 20(1):62–67 Schafer I, Hacker J, Rustenbach SJ, Radtke M, Franzke N, Augustin M (2010) Concordance of the psoriasis area and severity index (PASI) and patient-reported outcomes in psoriasis treatment. Euro J Dermatol 20(1):62–67
59.
Zurück zum Zitat Schmieder A, Schaarschmidt ML, Umar N, Terris DD, Goebeler M, Goerdt S, Peitsch WK (2012) Comorbidities significantly impact patients’ preferences for psoriasis treatments. J Am Acad Dermatol 67(3):363–372CrossRefPubMed Schmieder A, Schaarschmidt ML, Umar N, Terris DD, Goebeler M, Goerdt S, Peitsch WK (2012) Comorbidities significantly impact patients’ preferences for psoriasis treatments. J Am Acad Dermatol 67(3):363–372CrossRefPubMed
60.
Zurück zum Zitat Shikiar R, Rentz AM (2004) Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value Health 7(2):204–215CrossRefPubMed Shikiar R, Rentz AM (2004) Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value Health 7(2):204–215CrossRefPubMed
61.
62.
Zurück zum Zitat Sticherling M, Eicke C, Anger T (2013) Practicability of combined treatment with calcipotriol/betamethasone gel (Daivobet(R) Gel) and improvement of quality of life in patients with psoriasis. J Dtsch Dermatol Ges 11(5):420–427PubMed Sticherling M, Eicke C, Anger T (2013) Practicability of combined treatment with calcipotriol/betamethasone gel (Daivobet(R) Gel) and improvement of quality of life in patients with psoriasis. J Dtsch Dermatol Ges 11(5):420–427PubMed
63.
Zurück zum Zitat Sylwestrzak G, Liu J, Stephenson JJ, Ruggieri AP, DeVries A (2014) Considering patient preferences when selecting anti-tumor necrosis factor therapeutic options. Am Health Drug Benefits 7(2):71–81PubMedPubMedCentral Sylwestrzak G, Liu J, Stephenson JJ, Ruggieri AP, DeVries A (2014) Considering patient preferences when selecting anti-tumor necrosis factor therapeutic options. Am Health Drug Benefits 7(2):71–81PubMedPubMedCentral
64.
Zurück zum Zitat Tan J, Stacey D, Fung K, Barankin B, Bissonnette R, Gulliver W, Lui H, Shear N, Jackson C, Zhang XM (2010) Treatment decision needs of psoriasis patients: cross-sectional survey. J Cutan Med Surg 14(5):233–239CrossRefPubMed Tan J, Stacey D, Fung K, Barankin B, Bissonnette R, Gulliver W, Lui H, Shear N, Jackson C, Zhang XM (2010) Treatment decision needs of psoriasis patients: cross-sectional survey. J Cutan Med Surg 14(5):233–239CrossRefPubMed
65.
Zurück zum Zitat Tan J, Wolfe B (2012) A patient decision aid for psoriasis based on current clinical practice guidelines. Arch Dermatol 148(6):718–723CrossRefPubMed Tan J, Wolfe B (2012) A patient decision aid for psoriasis based on current clinical practice guidelines. Arch Dermatol 148(6):718–723CrossRefPubMed
66.
Zurück zum Zitat Tan J, Wolfe B (2014) Improved decisional conflict and preparedness for decision making using a patient decision aid for treatment selection in psoriasis: a pilot study. J Cutan Med Surg 18(2):114–118CrossRefPubMed Tan J, Wolfe B (2014) Improved decisional conflict and preparedness for decision making using a patient decision aid for treatment selection in psoriasis: a pilot study. J Cutan Med Surg 18(2):114–118CrossRefPubMed
67.
Zurück zum Zitat Torbica A, Fattore G, Ayala F (2014) Eliciting preferences to inform patient-centred policies: the case of psoriasis. Pharmacoeconomics 32(2):209–223CrossRefPubMed Torbica A, Fattore G, Ayala F (2014) Eliciting preferences to inform patient-centred policies: the case of psoriasis. Pharmacoeconomics 32(2):209–223CrossRefPubMed
69.
Zurück zum Zitat Umar N, Schaarschmidt M, Schmieder A, Peitsch WK, Schollgen I, Terris DD (2013) Matching physicians’ treatment recommendations to patients’ treament preferences is associated with improvement in treatment satisfaction. J Eur Acad Dermatol Venereol 27(6):763–770CrossRefPubMed Umar N, Schaarschmidt M, Schmieder A, Peitsch WK, Schollgen I, Terris DD (2013) Matching physicians’ treatment recommendations to patients’ treament preferences is associated with improvement in treatment satisfaction. J Eur Acad Dermatol Venereol 27(6):763–770CrossRefPubMed
71.
Zurück zum Zitat Umar N, Yamamoto S, Loerbroks A, Terris D (2012) Elicitation and use of patients’ preferences in the treatment of psoriasis: a systematic review. Acta Derm Venereol 92(4):341–346CrossRefPubMed Umar N, Yamamoto S, Loerbroks A, Terris D (2012) Elicitation and use of patients’ preferences in the treatment of psoriasis: a systematic review. Acta Derm Venereol 92(4):341–346CrossRefPubMed
72.
Zurück zum Zitat Van Cranenburgh OD, De Korte J, Sprangers MAG, De Rie MA, Smets EMA (2013) Satisfaction with treatment among patients with psoriasis: a web-based survey study. Br J Dermatol 169(2):398–405CrossRefPubMed Van Cranenburgh OD, De Korte J, Sprangers MAG, De Rie MA, Smets EMA (2013) Satisfaction with treatment among patients with psoriasis: a web-based survey study. Br J Dermatol 169(2):398–405CrossRefPubMed
73.
Zurück zum Zitat van den Reek JM, van Luumig PP, Otero ME, Zweegers J, van de Kerkhof PC, Ossenkoppele PM, Njoo MD, Mommers JM, Koetsier MI, Arnold WP, Sybrandy-Fleuren BA, Kuijpers AL, Andriessen MP, Seyger MM, Kievit W, de Jong EM (2014) Satisfaction of treatment with biologics is high in psoriasis: results from the Bio-CAPTURE network. Br J Dermatol 170(5):1158–1165CrossRefPubMed van den Reek JM, van Luumig PP, Otero ME, Zweegers J, van de Kerkhof PC, Ossenkoppele PM, Njoo MD, Mommers JM, Koetsier MI, Arnold WP, Sybrandy-Fleuren BA, Kuijpers AL, Andriessen MP, Seyger MM, Kievit W, de Jong EM (2014) Satisfaction of treatment with biologics is high in psoriasis: results from the Bio-CAPTURE network. Br J Dermatol 170(5):1158–1165CrossRefPubMed
74.
Zurück zum Zitat Vender R, Lynde C, Gilbert M, Ho V, Sapra S, Poulin-Costello M (2012) Etanercept improves quality of life outcomes and treatment satisfaction in patients with moderate to severe plaque psoriasis in clinical practice. J Cutan Med Surg 16(6):407–416CrossRefPubMed Vender R, Lynde C, Gilbert M, Ho V, Sapra S, Poulin-Costello M (2012) Etanercept improves quality of life outcomes and treatment satisfaction in patients with moderate to severe plaque psoriasis in clinical practice. J Cutan Med Surg 16(6):407–416CrossRefPubMed
75.
Zurück zum Zitat Zhang ML, Carter C, Olson WH, Johnson MP, Brenneman SK, Lee S, Farahi K (2017) Patient preference for dosing frequency based on prior biologic experience. J Drugs Dermatol 16(3):220–226PubMed Zhang ML, Carter C, Olson WH, Johnson MP, Brenneman SK, Lee S, Farahi K (2017) Patient preference for dosing frequency based on prior biologic experience. J Drugs Dermatol 16(3):220–226PubMed
76.
Zurück zum Zitat Zschocke I, Mrowietz U, Lotzin A, Karakasili E, Reich K (2014) Assessing adherence factors in patients under topical treatment: development of the topical therapy adherence questionnaire (TTAQ). Arch Dermatol Res 306(3):287–297CrossRefPubMedPubMedCentral Zschocke I, Mrowietz U, Lotzin A, Karakasili E, Reich K (2014) Assessing adherence factors in patients under topical treatment: development of the topical therapy adherence questionnaire (TTAQ). Arch Dermatol Res 306(3):287–297CrossRefPubMedPubMedCentral
Metadaten
Titel
Treatment preferences and treatment satisfaction among psoriasis patients: a systematic review
verfasst von
Aleksandra G. Florek
Catherine J. Wang
April W. Armstrong
Publikationsdatum
13.02.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Dermatological Research / Ausgabe 4/2018
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-018-1808-x

Weitere Artikel der Ausgabe 4/2018

Archives of Dermatological Research 4/2018 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.